Cargando…

A Mendelian randomization study for drug repurposing reveals bezafibrate and fenofibric acid as potential osteoporosis treatments

Background: Lipid pathways have been implicated in the pathogenesis of osteoporosis (OP). Lipid-lowering drugs may be used to prevent and treat OP. However, the causal interpretation of results from traditional observational designs is controversial by confounding. We aimed to investigate the causal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xiao-Hua, Pang, Wei-Wei, Zhang, Yue, Liu, Dan-Yang, Yi, Qiao-Rong, Wang, Ning, Zhang, Fu-Rong, Deng, Yun, Chen, Xiang-Ding, Greenbaum, Jonathan, Xiao, Hong-Mei, Deng, Hong-Wen, Tan, Li-Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397407/ https://www.ncbi.nlm.nih.gov/pubmed/37547327 http://dx.doi.org/10.3389/fphar.2023.1211302

Ejemplares similares

Coadministration of Compound Danshen dripping pills and bezafibrate has a protective effect against diabetic retinopathy
por: Liu, Le, et al.
Publicado: (2022)

Functional and Structural Insights into Human PPARα/δ/γ Subtype Selectivity of Bezafibrate, Fenofibric Acid, and Pemafibrate
por: Honda, Akihiro, et al.
Publicado: (2022)

Anticancer Properties of Fenofibrate: A Repurposing Use
por: Lian, Xin, et al.
Publicado: (2018)

A bi-directional Mendelian randomization study of the sarcopenia-related traits and osteoporosis
por: Ma, Xue-Ying, et al.
Publicado: (2022)

Drug Repurposing for COVID-19 Treatment by Integrating Network Pharmacology and Transcriptomics
por: Liu, Dan-Yang, et al.
Publicado: (2021)

Fenofibrate suppresses corneal neovascularization by regulating lipid metabolism through PPARα signaling pathway
por: Zhou, Tong, et al.
Publicado: (2022)

Maternally inherited diabetes and deafness coexists with lipoprotein lipase gene mutation‐associated severe hyperlipidemia that was resistant to fenofibrate and atorvastatin, but sensitive to bezafibrate: A case report
por: Zhang, Xiaojuan, et al.
Publicado: (2021)

Protective effect of antihypertensive drugs on the risk of Parkinson’s disease lacks causal evidence from mendelian randomization
por: Jiang, Zheng, et al.
Publicado: (2023)

Fenofibrate Improves Insulin Resistance and Hepatic Steatosis and Regulates the Let-7/SERCA2b Axis in High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease Mice
por: Zhang, Dan, et al.
Publicado: (2022)

Bezafibrate for X-Linked Adrenoleukodystrophy
por: Engelen, Marc, et al.
Publicado: (2012)

Therapy of Canine Hyperlipidemia with Bezafibrate
por: De Marco, V., et al.
Publicado: (2017)

Systematic evaluation for the causal effects of blood metabolites on osteoporosis: Genetic risk score and Mendelian randomization
por: Yu, Xing-Hao, et al.
Publicado: (2022)

Systematic review and meta-analysis: bezafibrate in patients with primary biliary cirrhosis
por: Yin, Qin, et al.
Publicado: (2015)

Fenofibrate Decreases Hepatic P-Glycoprotein in a Rat Model of Hereditary Hypertriglyceridemia
por: Poruba, Martin, et al.
Publicado: (2019)

Recent Progresses in the Treatment of Osteoporosis
por: Li, Shan-Shan, et al.
Publicado: (2021)

Inflammatory Cytokines and Risk of Ischemic Stroke: A Mendelian Randomization Study
por: Li, Yalan, et al.
Publicado: (2022)

Efficacy and safety of fenofibrate add-on therapy in patients with primary biliary cholangitis refractory to ursodeoxycholic acid: A retrospective study and updated meta-analysis
por: Guoyun, Xuan, et al.
Publicado: (2022)

Eldecalcitol prevented OVX-induced osteoporosis through inhibiting BMSCs senescence by regulating the SIRT1-Nrf2 signal
por: Kou, Yuying, et al.
Publicado: (2023)

Activation of Sterol Regulatory Element Binding Factors by Fenofibrate and Gemfibrozil Stimulates Myelination in Zebrafish
por: Ashikawa, Yoshifumi, et al.
Publicado: (2016)

Therapeutic effect of fenofibrate for non-alcoholic steatohepatitis in mouse models is dependent on regime design
por: Wang, Xinxue, et al.
Publicado: (2023)

The Hyperlipidaemic Drug Fenofibrate Significantly Reduces Infection by SARS-CoV-2 in Cell Culture Models
por: Davies, Scott P., et al.
Publicado: (2021)

Update on the use of fibrates: focus on bezafibrate
por: Goldenberg, Ilan, et al.
Publicado: (2008)

Metabolic effects of bezafibrate in mitochondrial disease
por: Steele, Hannah, et al.
Publicado: (2020)

An Integrated Metabolomic Study of Osteoporosis: Discovery and Quantification of Hyocholic Acids as Candidate Markers
por: Deng, Dawei, et al.
Publicado: (2021)

Lipid changes due to fenofibrate treatment are not associated with changes in DNA methylation patterns in the GOLDN study
por: Das, Mithun, et al.
Publicado: (2015)

Repurposing Approved Drugs for Sarcopenia Based on Transcriptomics Data in Humans
por: Liang, Shuang, et al.
Publicado: (2023)

Disulfiram in glioma: Literature review of drug repurposing
por: Zhong, Shiyu, et al.
Publicado: (2022)

Evidence synthesis of Chinese medicine for monkeypox: Suggestions from other contagious pox-like viral diseases
por: Rong, Hong-guo, et al.
Publicado: (2023)

Repurposing Artemisinin and its Derivatives as Anticancer Drugs: A Chance or Challenge?
por: Ma, Zhaowu, et al.
Publicado: (2021)

Therapeutic Effectiveness and Safety of Repurposing Drugs for the Treatment of COVID-19: Position Standing in 2021
por: Alam, Safaet, et al.
Publicado: (2021)

Drug repurposing for Alzheimer’s disease from 2012–2022—a 10-year literature review
por: Grabowska, Monika E., et al.
Publicado: (2023)

Untargeted Metabolomics Reveals the Protective Effect of Fufang Zhenshu Tiaozhi (FTZ) on Aging-Induced Osteoporosis in Mice
por: Luo, Duosheng, et al.
Publicado: (2019)

Protective Effects of Punicalagin on Osteoporosis by Inhibiting Osteoclastogenesis and Inflammation via the NF-κB and MAPK Pathways
por: Wang, Wei, et al.
Publicado: (2020)

Bezafibrate Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis
por: Xu, Si-Chi, et al.
Publicado: (2017)

Nutritional background changes the hypolipidemic effects of fenofibrate in Nile tilapia (Oreochromis niloticus)
por: Ning, Li-Jun, et al.
Publicado: (2017)

Editorial: Cancer neuroscience: Drug repurposing targeting the innervated niche
por: Jin, Ming-Zhu, et al.
Publicado: (2023)

Effects and mechanisms of natural alkaloids for prevention and treatment of osteoporosis
por: Lin, Bingfeng, et al.
Publicado: (2022)

Hydroxy-Safflower Yellow A Alleviates Osteoporosis in Ovariectomized Rat Model by Inhibiting Carbonic Anhydrase 2 Activity
por: Wang, Yang, et al.
Publicado: (2021)

Gut Metabolite Urolithin A Inhibits Osteoclastogenesis and Senile Osteoporosis by Enhancing the Autophagy Capacity of Bone Marrow Macrophages
por: Tao, Huaqiang, et al.
Publicado: (2022)

Causal association of epigenetic aging and osteoporosis: a bidirectional Mendelian randomization study
por: Liang, Xinyu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_792fi86k4klfcg4q3bpntqd7n0